IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM
- DOI
- 10.1182/bloodadvances.2025018537
- Published
- 2026-04-15
- Container
- Blood Advances
- Publisher
- American Society of Hematology
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2025018537,
title = {IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM},
author = {Kylee H. Maclachlan and Carlyn R. Tan and Tala Shekarkhand and Colin Rueda and Andriy Derkach and Hamza Hashmi and Hani Hassoun and Urvi A. Shah and Malin Hultcrantz and Alexander M. Lesokhin and Sham Mailankody and Francesco Maura and Maximillian Merz and Ross Firestone and Eric M. Jurgens and Kevin C. Miller and Sridevi Rajeeve and Sergio Giralt and Gunjan L. Shah and Michael Scordo and Heather J. Landau and Yanming Zhang and Robert Cimera and Maria E. Arcila and Neha Korde and Saad Z. Usmani},
year = {2026},
journal = {Blood Advances},
doi = {10.1182/bloodadvances.2025018537},
url = {https://doi.org/10.1182/bloodadvances.2025018537}
}RIS
TY - JOUR TI - IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM AU - Kylee H. Maclachlan AU - Carlyn R. Tan AU - Tala Shekarkhand AU - Colin Rueda AU - Andriy Derkach AU - Hamza Hashmi AU - Hani Hassoun AU - Urvi A. Shah AU - Malin Hultcrantz AU - Alexander M. Lesokhin AU - Sham Mailankody AU - Francesco Maura AU - Maximillian Merz AU - Ross Firestone AU - Eric M. Jurgens AU - Kevin C. Miller AU - Sridevi Rajeeve AU - Sergio Giralt AU - Gunjan L. Shah AU - Michael Scordo AU - Heather J. Landau AU - Yanming Zhang AU - Robert Cimera AU - Maria E. Arcila AU - Neha Korde AU - Saad Z. Usmani PY - 2026 JO - Blood Advances DO - 10.1182/bloodadvances.2025018537 UR - https://doi.org/10.1182/bloodadvances.2025018537 ER -
APA
Maclachlan, K. H., Tan, C. R., Shekarkhand, T., Rueda, C., Derkach, A., Hashmi, H., Hassoun, H., Shah, U. A., Hultcrantz, M., Lesokhin, A. M., Mailankody, S., Maura, F., Merz, M., Firestone, R., Jurgens, E. M., Miller, K. C., Rajeeve, S., Giralt, S., Shah, G. L., Scordo, M., Landau, H. J., Zhang, Y., Cimera, R., Arcila, M. E., Korde, N., & Usmani, S. Z. (2026). IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM. Blood Advances. https://doi.org/10.1182/bloodadvances.2025018537
Source records
- crossref · retrieved 2026-09-27T17:23:18.882Z